生物电阻抗分析定量评估头颈癌放疗患者肌少症
这项前瞻性观察研究纳入50例接受放疗的头颈癌患者,比较诊室内多频生物电阻抗分析(BIA)与CT估算的体成分,并用ROC曲线确定BIA肌少症阈值;48例可评估患者中BIA与CT强相关,BIA或CT定义的肌少症均与总生存期(OS)下降相关。
要点
- BIA测骨骼肌量、去脂体重和脂肪量与CT估算强相关。
- 男性骨骼肌质量指数<9.19 kg/m2诊断肌少症敏感度和特异度高。
- BIA或CT定义的肌少症患者总生存期均较短。
核心结论
- BIA可准确估算头颈癌患者体成分,临床使用BIA可能识别生存较差的肌少症患者。
研究设计与样本
- 前瞻性观察研究纳入50例接受放疗的头颈癌患者,48例可评估。
- 基线BIA测骨骼肌量、去脂体重和脂肪量,与CT估算用线性回归比较。
- 用ROC曲线最大Youden指数确定性别特异性BIA肌少症阈值,按肌少症状态分层用Kaplan-Meier法和log-rank检验比较OS。
主要发现
- BIA与CT测骨骼肌量强相关(r=0.97;R2=0.94;p<0.0001)。
- BIA与CT测去脂体重强相关(r=0.97;R2=0.94;p<0.0001)。
- BIA与CT测脂肪量强相关(r=0.95;R2=0.90;p<0.0001)。
- CT或BIA定义的肌少症患者OS均下降(CT p=0.009;BIA p=0.03;HR=不可估计)。
关键数值与推荐
- 男性骨骼肌质量指数<9.19 kg/m2诊断肌少症敏感度91.7%、特异度92.9%。
- 女性骨骼肌质量指数<6.53 kg/m2诊断肌少症敏感度100%,但特异度不高。
临床怎么用
- 可在临床中用多频BIA估算头颈癌放疗患者体成分并识别肌少症。
- BIA-derived阈值可用于筛查生存风险较高的肌少症患者。
局限性
- 样本量50例,可评估48例,研究为单中心前瞻性观察。
- 女性BIA阈值敏感度100%但特异度不高。
- 肌少症与OS比较的HR不可估计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Sarcopenia is associated with decreased survival in head and neck cancer patients treated with radiotherapy. This study sought to determine whether in-clinic multifrequency bioelectrical impedance analysis (BIA) can identify survival-associated sarcopenia in patients with head and neck cancer. MATERIALS AND METHODS: This prospective observational study enrolled 50 patients with head and neck cancer undergoing radiation therapy. Baseline BIA measures of skeletal muscle (SM) mass, fat-free mass (FFM), and fat mass (FM) were compared to CT-based estimates using linear regression. Sex-specific BIA-derived thresholds for sarcopenia were defined by the maximum Youden Index on receiver operator characteristic (ROC) curves. Patients were stratified by sarcopenia status and OS was compared using the Kaplan-Meier method and log-rank test. RESULTS: Among 48 evaluable patients, BIA measures of body composition were strongly correlated with CT measures: SM mass (r = 0.97; R2 = 0.94; p < 0.0001), FFM (r = 0.97; R2 = 0.94; p < 0.0001) and FM (r = 0.95; R2 = 0.90; p < 0.0001). SM mass index < 9.19 kg/m2 identified sarcopenia men with high sensitivity (91.7%) and specificity (92.9%), whereas in women SM mass index < 6.53 kg/m2 was sensitive for sarcopenia (100%), but not specific. Patients with sarcopenia, defined by either CT or BIA, exhibited decreased OS (HR = not estimable; CT p = 0.009; BIA p = 0.03). CONCLUSION: BIA provides accurate estimates of body composition in head and neck cancer patients. Implementation of BIA in clinical practice may identify patients with sarcopenia at risk for poor survival.
引用
- Grossberg AJ, Rock CD, Edwards J, et al. Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy. Radiother Oncol. 2021. PMID: 33736997. doi:10.1016/j.radonc.2021.03.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。